Serving Australia and NZ
1300 543 373
Return to Previous Page

CL429 VacciGrade™, 5 mg

CL429 VacciGrade™, 5 mg

Quick Overview:

Product Code: vac-c429
Supplier: InvivoGen

  • Details

    Dual TLR2 & NOD2 agonist CL429 is a chimeric compound that stimulates both TLR2 and NOD2. This compound is composed of murabutide (NOD2 ligand) covalently linked to Pam2C (TLR2 ligand) via a spacer. CL429 was shown to induce synergistic human DC maturation in vitro and to significantly enhance both systemic and mucosal immunity against a vaccine antigen. The very potent adjuvant activity of CL429 is associated with no apparent toxicity. This activity seems to be mediated by an optimal DC maturation process, which induces strong B and T cell stimulation and autophagy. CL429 VacciGrade™ is suitable for preclinical studies. It is prepared under strict aseptic conditions. It is guaranteed sterile and thoroughly tested for the presence of endotoxins.
  • Additional Information

    Supplier name InvivoGen
    Product Type Reagents
    Size 5 mg,5 mg
    Publications Publication List
    Datasheet URL View Datasheet
    Categories Reagents,Vaccine Adjuvants & Reagents,COVID-19 Products
  • Images